MedTrace Logo

Treatment and/or Prevention of Urinary Tract Infections

NCT00801021 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2010-03-08

No results posted yet for this study

Summary

The purpose of the study is to determine the effect of an investigational oral rinse in reducing uropathogens and treating uncomplicated urinary tract infections.

Conditions

Interventions

DRUG

Frio Mouth Rinse

Rinse with 15ml twice daily then expectorate

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Baylor College of Medicine

    collaborator OTHER

  • Biomedical Development Corporation

    lead INDUSTRY

Principal Investigators

  • Barbara W. Trautner, M.D., Ph.D. · Baylor College of Medicine

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00801021 on ClinicalTrials.gov